'Generic competition' diaporamas de présentation

IMRS CI 2008 Topics Course No.1

IMRS CI 2008 Topics Course No.1 . The TRIPS and Public Health Debate Do Intellectual Property Rights Facilitate Research and Development in new Pharmaceuticals or Hinder Access to Medication? . Issues. The Link between International IP protection, Free Trade and Public Health

541 views • 44 slides

Target 2010 The Toyota of Pharma

Target 2010 The Toyota of Pharma. Tom van Laar Head of Global Technical Operations Novartis Pharma AG. Agenda. Novartis Global Technical Operations. 24 Chemical, Pharmaceutical and BioPharma Plants 350 brands, 20,000 finished product SKUs 8 major 3 rd parties 9,000 employees worldwide.

529 views • 30 slides

The Role of IP and Trademarks, and Other Distinctive Signs, in Enhancing the Competitiveness of Business Julian Nolan

The Role of IP and Trademarks, and Other Distinctive Signs, in Enhancing the Competitiveness of Business Julian Nolan. Agenda. The business of trademarks BMW vs VW case study Fashion industry case studies IP and product development Processes and good business practice

467 views • 30 slides

Analysis of Competition

Analysis of Competition. Dealing with the Competition. Poor firms ignore their competitors; average firms copy their competitors; winning firms lead their competitors. Philip Kotler. Why to analyze competitors?. Knowing the competitors is critical to effective marketing planning

363 views • 27 slides

216 views • 21 slides

Generic substitution and licensing

1.22k views • 19 slides

Entry costs and market structure

Entry costs and market structure. There are many potential entrants into a market. Entrants simultaneously decide whether or not to enter the industry. Entry costs F, which is not recoverable if the firm decides to exit the industry.

339 views • 13 slides

Generic Competition

226 views • 11 slides

Generic Competition

361 views • 11 slides

SALES (US$BN)

175 views • 1 slides